Standard BioTools Reports First Quarter 2024 Financial Results
Standard BioTools Inc. (LAB)
Company Research
Source: GlobeNewswire
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of approximately $21 million, and non-GAAP operating expense reduction of approximately $17 millionOn track to cash flow positive in full-year 2026 with current balance sheet of $464 million cash, cash equivalents, restricted cash and short-term investments SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced financial results for the first quarter ended March 31, 2024 and recent business updates. Standard BioTools First Quarter Financial Results As Reported Pro Forma Combined (a) Quarter Ended Quarter Ended March 31, 2024 March 31, 2024March 31, 2023Revenue$45.5 $46.2 $45.5
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthGlobeNewswire
LAB
Earnings
- 5/8/24 - Miss
LAB
Sec Filings
- 5/17/24 - Form 4
- 5/16/24 - Form 4
- 5/10/24 - Form PREC14A
- LAB's page on the SEC website